Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Jones Lang LaSalle Inc (JLL) Price & Performance

Axogen IncTrade
Jones Lang LaSalle IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Jones Lang LaSalle Inc — how do they compare? Axogen Inc trades at $38.7 (market cap $2.06B), while Jones Lang LaSalle Inc trades at $333.97 (market cap $14.94B). The key difference: Jones Lang LaSalle Inc is far larger — about 7.3× Axogen Inc's market cap. Which is the better fit depends on your goals.

AXGNJLL
Market Cap
$2.06B$14.94B
Sector
TechnologyReal Estate
52-Week High
$46.19$358.66
52-Week Low
$11.28$248.95
Enterprise Value
$1.98B$18.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

Jones Lang LaSalle Inc

JLL trades at $321.95, down 0.77% today, with a bullish technical outlook supported by moving averages and strong support near $319. The company shows robust fundamentals with revenue growth to $26.12B in 2025 and consistent earnings beats, while valuation ratios like P/E of 17.32 and P/S of 0.58 appear reasonable. Recent news highlights significant refinancing deals and positive AI workforce studies, reinforcing business momentum.

JLL offers a favorable risk-reward profile with a consensus price target of $405.50 implying 26% upside, backed by analyst optimism and improving cash flows. Key risks include economic sensitivity to real estate cycles and competitive pressures. The stock presents a growth opportunity driven by operational execution and market leadership, though investors should monitor debt levels and macroeconomic trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL